Biktarvy, formally known as bictegravir, is a potent single-tablet therapy for controlling HIV infection. This medication combines three crucial antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the HIV's ability to copy within the body, remarkably reducing the viral quantity. For many individuals,